Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.

Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes.

Lohmann T, Laue S, Nietzschmann U, Kapellen TM, Lehmann I, Schroeder S, Paschke R, Kiess W.

Diabetes. 2002 Aug;51(8):2474-80.

2.

Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.

Yamamoto J, Adachi Y, Onoue Y, Adachi YS, Okabe Y, Itazawa T, Toyoda M, Seki T, Morohashi M, Matsushima K, Miyawaki T.

J Leukoc Biol. 2000 Oct;68(4):568-74.

PMID:
11037980
3.

Characterization of chemokine receptor expression and cytokine production in circulating CD4+ T cells from patients with atopic dermatitis: up-regulation of C-C chemokine receptor 4 in atopic dermatitis.

Okazaki H, Kakurai M, Hirata D, Sato H, Kamimura T, Onai N, Matsushima K, Nakagawa H, Kano S, Minota S.

Clin Exp Allergy. 2002 Aug;32(8):1236-42.

PMID:
12190665
4.

Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease.

Aso Y, Matsuura H, Momobayashi A, Inukai Y, Sugawara N, Nakano T, Yamamoto R, Wakabayashi S, Takebayashi K, Inukai T.

Endocr J. 2006 Jun;53(3):377-85. Epub 2006 May 23.

5.

C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.

Andrew DP, Ruffing N, Kim CH, Miao W, Heath H, Li Y, Murphy K, Campbell JJ, Butcher EC, Wu L.

J Immunol. 2001 Jan 1;166(1):103-11.

6.

Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.

Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C, Sozzani S, Girolomoni G, Cavani A.

J Immunol. 2001 Jan 15;166(2):996-1002.

7.

Switch in chemokine receptor phenotype on memory T cells without a change in the cytokine phenotype.

Aarvak T, Strand E, Teigland J, Miossec P, Natvig JB.

Scand J Immunol. 2001 Jul-Aug;54(1-2):100-8.

8.

Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.

Katschke KJ Jr, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE.

Arthritis Rheum. 2001 May;44(5):1022-32.

9.

IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.

Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.

J Leukoc Biol. 2002 Oct;72(4):735-42.

PMID:
12377943
10.

Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.

Juffermans NP, Paxton WA, Dekkers PE, Verbon A, de Jonge E, Speelman P, van Deventer SJ, van der Poll T.

Blood. 2000 Oct 15;96(8):2649-54.

11.

Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.

Casas R, Lindau C, Zetterström O, Duchén K.

Scand J Immunol. 2008 Sep;68(3):351-61. doi: 10.1111/j.1365-3083.2008.02146.x.

12.

Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 gamma delta T lymphocytes.

Dagna L, Iellem A, Biswas P, Resta D, Tantardini F, Fortis C, Sabbadini MG, D'Ambrosio D, Manfredi AA, Ferrarini M.

Eur J Immunol. 2002 Oct;32(10):2934-43.

13.

Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.

Fischer FR, Santambrogio L, Luo Y, Berman MA, Hancock WW, Dorf ME.

J Neuroimmunol. 2000 Oct 2;110(1-2):195-208.

PMID:
11024550
14.

Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response.

Kondo T, Nakazawa H, Ito F, Hashimoto Y, Osaka Y, Futatsuyama K, Toma H, Tanabe K.

Cancer Sci. 2006 Aug;97(8):780-6.

15.

Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells.

Langenkamp A, Nagata K, Murphy K, Wu L, Lanzavecchia A, Sallusto F.

Eur J Immunol. 2003 Feb;33(2):474-82.

16.

Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.

Annunziato F, Galli G, Nappi F, Cosmi L, Manetti R, Maggi E, Ensoli B, Romagnani S.

Blood. 2000 Feb 15;95(4):1167-74.

17.
18.

High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes.

Stechova K, Bohmova K, Vrabelova Z, Sepa A, Stadlerova G, Zacharovova K, Faresjö M.

Diabetes Metab Res Rev. 2007 Sep;23(6):462-71.

PMID:
17315139
19.

Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease.

Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS.

J Periodontal Res. 2003 Apr;38(2):210-7.

PMID:
12608917
20.

Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.

Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):122-31.

PMID:
11832680

Supplemental Content

Support Center